AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+9.75%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$135M
AUM Growth
+$135M
(-0.95%)
Cap. Flow
-$14.5M
Cap. Flow
% of AUM
-10.77%
Top 10 Holdings %
Top 10 Hldgs %
21.49%
Holding
245
New
28
Increased
32
Reduced
137
Closed
15
Top Buys
| 1 |
Merck
MRK
|
$2.73M |
| 2 |
Indivior
INDV
|
$2.36M |
| 3 |
Alphatec Holdings
ATEC
|
$2.06M |
| 4 |
Neurocrine Biosciences
NBIX
|
$1.79M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$1.37M |
Top Sells
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$4.17M |
| 2 |
Pacira BioSciences
PCRX
|
$3.36M |
| 3 |
Pfizer
PFE
|
$3.04M |
| 4 |
United Therapeutics
UTHR
|
$2.96M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$2.13M |
Sector Composition
| 1 | Healthcare | 57.92% |
| 2 | Real Estate | 14.45% |
| 3 | Financials | 7.05% |
| 4 | Industrials | 3.2% |
| 5 | Technology | 2.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCYC
51
Bicycle Therapeutics
BCYC
$492M
| $849K | 0.63% |
37,500
-22,500
| -38% | -$509K |
|
|
ONIT
52
Onity Group Inc.
ONIT
$339M
| $817K | 0.61% |
25,567
| – | – |
|
53
Penumbra
PEN
$10.5B
| $777K | 0.58% |
+4,000
| New | +$777K |
|
54
NVIDIA
NVDA
$4.15T
| $726K | 0.54% |
5,981
-28
| -0.5% | -$3.4K |
|
|
VALN
55
Valneva
VALN
$746M
| $717K | 0.53% |
118,000
+29,748
| +34% | +$181K |
|
56
Nuvalent
NUVL
$5.74B
| $716K | 0.53% |
+7,000
| New | +$716K |
|
57
MoonLake Immunotherapeutics
MLTX
$3.78B
| $706K | 0.52% |
+14,000
| New | +$706K |
|
58
Cytokinetics
CYTK
$5.98B
| $660K | 0.49% |
+12,500
| New | +$660K |
|
59
Procept Biorobotics
PRCT
$2.11B
| $641K | 0.48% |
8,000
-2,000
| -20% | -$160K |
|
60
Accuray
ARAY
$165M
| $630K | 0.47% |
350,000
| – | – |
|
61
Acadia Pharmaceuticals
ACAD
$4.34B
| $615K | 0.46% |
40,000
-60,000
| -60% | -$923K |
|
62
Intuitive Surgical
ISRG
$158B
| $614K | 0.46% |
1,250
-750
| -38% | -$368K |
|
63
Symbotic
SYM
$5.06B
| $610K | 0.45% |
25,000
+5,000
| +25% | +$122K |
|
64
Cognex
CGNX
$7.38B
| $608K | 0.45% |
+15,000
| New | +$608K |
|
65
Rockwell Automation
ROK
$38.1B
| $604K | 0.45% |
+2,250
| New | +$604K |
|
66
SoundHound AI
SOUN
$5.19B
| $583K | 0.43% |
125,000
-25,000
| -17% | -$117K |
|
67
Hartford Financial Services
HIG
$37.4B
| $523K | 0.39% |
4,451
-202
| -4% | -$23.8K |
|
68
iShares MSCI Australia ETF
EWA
$1.51B
| $522K | 0.39% |
19,248
-605
| -3% | -$16.4K |
|
69
Sagimet Biosciences
SGMT
$239M
| $512K | 0.38% |
185,000
| – | – |
|
70
Embecta
EMBC
$837M
| $508K | 0.38% |
36,000
-20,500
| -36% | -$289K |
|
71
Synopsys
SNPS
$110B
| $506K | 0.38% |
1,000
-1,000
| -50% | -$506K |
|
72
VYNE Therapeutics
VYNE
$8.09M
| $505K | 0.38% |
268,485
-42,015
| -14% | -$79K |
|
73
AeroVironment
AVAV
$11.9B
| $501K | 0.37% |
2,500
-650
| -21% | -$130K |
|
74
Apogee Therapeutics
APGE
$2.27B
| $499K | 0.37% |
+8,500
| New | +$499K |
|
75
JPMorgan BetaBuilders Japan ETF
BBJP
$13.7B
| $496K | 0.37% |
8,363
-260
| -3% | -$15.4K |
|